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A Lymantria dispar nuclear polyhedrosis virus (LdMNPV) gene has been identified that encodes a homolog
to the granulovirus (GV) enhancin proteins that are capable of enhancing the infection of other baculoviruses.
Enhancin genes have been identified and sequenced for three species of GVs but have not been found in any
other nuclear polyhedrosis virus to date. The LdMNPV enhancin gene is located between 67.6 and 70.1 kbp on
the viral genome. Northern and primer extension analyses of viral RNAs indicate that the enhancin gene
transcripts are expressed at late times postinfection from a consensus baculovirus late promoter. The LdMNPV
enhancin exhibits 29% amino acid identity to the enhancin proteins of the Trichoplusia ni, Pseudaletia unipuncta,
and Helicoverpa armigera GVs. All four proteins contain a conserved zinc-binding domain characteristic of
metalloproteases. A recombinant virus (enhancin::cat) was constructed in which the LdMNPV enhancin gene
was inactivated by insertion mutagenesis in order to ascertain the effect of the enhancin protein on viral
potency. The bioassay results indicate that disruption of the enhancin gene in the LdMNPV results in a
reduction in viral potency.
midgut columnar cells, resulting in the insect’s increased susceptibility to viral infection (12). Second, there is an increased
fusion of the nucleocapsids with the midgut cells through interaction of the enhancin protein with both the viral envelope
and the cell plasma membrane (37, 39, 42, 45).
The Lymantria dispar NPV (LdMNPV) is pathogenic to the
gypsy moth, a forest and urban tree-defoliating pest in the
northeastern United States. The genome of the LdMNPV is
approximately 162 kbp in length (29), in contrast to the 133kbp genome of the prototype baculovirus, AcMNPV. The entire genome of the AcMNPV has been sequenced (2), and
although that of the LdMNPV is not as well characterized,
several genes which are present in both the LdMNPV and the
AcMNPV have been identified (6, 9, 31, 36). The extra 29 kbp
of DNA present in the LdMNPV suggests that this virus has
the potential to possess several genes which are not present in
the AcMNPV. Two genes, the host range factor 1 gene (43)
and G22 (5), that have been identified and characterized for
the LdMNPV do not have homologs in the AcMNPV. In this
study we extended the characterization of the LdMNPV by
cloning and sequencing the enhancin gene. Homologs of this
gene are present in the GVs but have not been identified in
any other NPV to date. We also explored the effect of the
LdMNPV enhancin protein on viral pathogenicity by inactivating the enhancin gene through insertional mutagenesis.

Nuclear polyhedrosis virus (NPVs) and granuloviruses
(GVs) are members of the Baculoviridae which infect insects
and other arthropods. All baculoviruses have a unique infection cycle in that they produce two infectious forms: a budded
virus, which infects different cell types within a single larva; and
an occlusion body, a form of the virus that is embedded in a
protein structure. Larvae are infected upon ingestion of the
occlusion body and release of the viral particles in the alkaline
environment of the midgut. In NPVs, many viral particles are
occluded in a single intranuclear crystal called a polyhedron,
whereas in GVs a single viral particle is found in each crystal,
or granule. The polyhedron protects the viral particles from
environmental elements and is the viral form that is used for
biocontrol of agricultural and forest insect pests (for a review
see reference 10).
Enhancin, which has also been referred to as the synergistic
or viral enhancing factor, is a protein found in the GV occlusion body that has the ability to enhance the infection of other
NPVs (15, 18, 37, 40, 41). The enhancin protein is highly
expressed in GVs and makes up approximately 5% of the total
protein in the granules (37). It has been localized deep within
the capsule matrix, close to the viral envelope (47, 49). Purified
enhancin from the Trichoplusia ni GV (TnGV) can enhance
the infection of the Autographa californica NPV (AcMNPV) 2to 4-fold when fed to T. ni larvae and up to 12-fold when fed
to other larvae such as those of Spodoptera exigua (45). Recently, enhancin genes have also been identified in the Pseudaletia unipuncta GV (PuGV) and the Helicoverpa armigera
GV (HaGV) (32).
Two modes of action have been observed for enhancin proteins. First, the enhancins exhibit proteolytic activity (16, 38)
which results in the enzymatic hydrolysis of the peritrophic
membrane (12, 45), a barrier against microbial pathogens in
the insect midgut. Degradation of the peritrophic membrane
by enhancin is believed to allow the virus easier access to the

MATERIALS AND METHODS
Cells, virus, and insects. L. dispar 652Y cells were grown as monolayers in
Goodwin’s IPL-52B medium supplemented with 6.25 mM glutamine and 10%
fetal bovine serum. Cell cultures were inoculated with either LdMNPV isolate
A21-MPV (35), which produces wild-type polyhedra, or the enhancin::cat virus
(in which enhancin is disrupted by a chloramphenicol acetyltransferase [cat]
gene). L. dispar egg masses were obtained from the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service rearing facility at Otis Air
Force Base (Mass.). Hatched larvae were reared on a gypsy moth diet (3).
Viral DNA isolation and Southern blot analysis. Budded virus was isolated
from infected 652Y cells as described previously (4) and used as a source of
genomic DNA for restriction analysis. Viral DNA was digested with restriction endonucleases and fractionated on 1.0% agarose–Tris-borate-EDTA
gels. Southern blot analysis was performed on nitrocellulose with probes labeled
with the nick translation kit (Bethesda Research Laboratories) and [a-32P]dCTP
(NEN).

* Corresponding author. Phone: (614) 368-0033. Fax: (614) 3680152.
8133

This article is a U.S. government work, and is not subject to copyright in the United States.

8134

BISCHOFF AND SLAVICEK

Sequencing. The sequence of the enhancin gene from isolate A21-MPV was
determined for both strands by the dideoxynucleotide sequencing method. Plasmid and single-strand M13 DNA templates were sequenced with the Sequenase
version 2.0 DNA sequencing kit (U.S. Biochemicals) or the fmol DNA sequencing system (Promega) by using the protocols supplied with the kits. a-35S-dATP
was supplied by NEN. Sequence analysis was done with the MacVector program
(International Biotechnologies, Inc.).
In vitro transcription and translation of the enhancin gene. A 4.2-kbp SstII
fragment containing the enhancin gene was subcloned into pBluescript SK1
(Stratagene) to generate pDB126. The enhancin protein was expressed from
pDB126 with the TNT coupled reticulocyte lysate system and T7 RNA polymerase (Promega) per the directions provided with the kit. The expressed protein
was labeled by the addition of [35S]methionine (NEN). Reaction products were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) and autoradiography.
RNA isolation and Northern blot analysis. A21-MPV-infected 652Y cells were
harvested at various times postinfection (p.i.). Cytoplasmic RNA was isolated as
described by Friesen and Miller (14). RNA was separated on 1.2% agarose gels
containing formaldehyde and transferred to nitrocellulose. Northern blot analysis was performed as described by Mahmoudi and Lin (28). A 30-base oligonucleotide (complementary to positions 939 to 968 in Fig. 2) was end labeled
with [g-32P]ATP (NEN) and used as a strand-specific probe to detect the enhancin transcripts.
Primer extension mapping of transcripts. Primer extension reactions were
performed by the method of Crawford and Miller (11). Cytoplasmic RNA was
isolated at 48 and 72 h p.i. from 652Y cells infected with A21-MPV. An 18-base
oligonucleotide (complementary to positions 132 to 149 in Fig. 2) was used in the
reactions after being end labeled with [g-32P]ATP (NEN). The primer was
extended with Moloney murine leukemia virus reverse transcriptase. Primer
extension products were fractionated on 6% polyacrylamide–8 M urea gels and
visualized by autoradiography.
Construction of the enhancin::cat virus. A transplacement vector (pDB159)
containing the enhancin gene disrupted with the cat gene was constructed. Transfections were carried out with 2.5 mg of A21-MPV viral DNA and 2.5 mg of
pDB159 plasmid DNA by using the Lipofectin reagent (Bethesda Research
Laboratories) as described previously (6). At 7 days p.i., the cells and medium (3
ml) were collected and diluted with 12 ml of fresh medium in a T75 flask. The
nonoccluded virus was collected at 7 days p.i. and plaque purified. Approximately
200 plaques were picked and used to infect 652Y cells in P96 plates. To identify
recombinant viruses, budded virus (50 ml) from the P96 wells was blotted by
standard techniques and probed with the 0.7-kbp SstI fragment containing the cat
gene from pDB4 (8). For further details, see Results and Discussion.
Bioassay analysis of the enhancin::cat virus. Polyhedra were isolated from
652Y cells infected with either A21-MPV or the enhancin::cat virus and were
purified and quantitated as previously described (34). Fourth-instar L. dispar
larvae were infected per os by placing them on a diet containing surface-applied
in vitro-synthesized polyhedra (total of 5 3 106 polyhedra). The larvae were
placed on fresh food after 48 h on the infected diet. Dead larvae were collected
and used as a source of in vivo polyhedra for the bioassays. The polyhedra were
tested for biological activity by both the diet incorporation (23) and the droplet
feeding (21, 22) methods.
In the diet incorporation bioassays, second-instar larvae were infected by
placing them on a diet containing various concentrations of polyhedra (102 to 107
polyhedra per ml of diet) and allowing them to feed ad libitum for 48 h. Five
groups (20 larvae each) were infected at each virus dose. After 48 h on the diet
containing virus, the larvae were removed and placed on a fresh diet for the
remaining 12 days of the bioassay. This type of bioassay was repeated in triplicate.
In the droplet feeding assay, neonate larvae (60 larvae per dilution) were
allowed to feed for 30 min on droplets containing various dilutions of polyhedra
(5 3 103 to 106 polyhedra per ml of solution). The larvae were then placed on a
fresh diet and were monitored for death for up to 18 days. The volume of
solution ingested by L. dispar neonate larvae in the droplet feeding assay was
determined by the method of Kunimi and Fuxa (26).
Dead larvae from both bioassays were removed and counted daily. The 50%
lethal concentrations (LC50s) and 50% lethal times were determined for each
virus by Probit analysis (13) by using the POLO-PC program (LeOra Software,
Berkeley, Calif. [33]). The 50% lethal times and 50% lethal doses were also
determined for the droplet feeding method by using the ViStat program (version
2.1; Boyce Thompson Institute, Cornell University, Ithaca, N.Y. [20]).
Nucleotide sequence accession number. The nucleotide sequence accession
number of the sequence contained in this paper is AF019971.

RESULTS AND DISCUSSION
Identification of the enhancin gene. The enhancin gene was
identified during the mapping and sequencing of the gene
mutated in LdMNPV few polyhedron mutants. Initially these
mutations were mapped to a 4.3-kbp BamHI/EcoRI fragment
located at 64.5 to 68.9 kbp on the viral genome. Further map-
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FIG. 1. Genomic location of the LdMNPV enhancin gene. (A) BglII restriction map of the LdMNPV viral genome, with the letter designation of each
fragment shown above (6). The locations of other known LdMNPV genes are
also indicated. Abbreviations: polh, polyhedrin gene (36); 25K FP, 25K few
polyhedron gene (6); egt, ecdysteroid UDP-glucosyltransferase gene (31); DNA
pol, DNA polymerase gene (9); hrf-1, host range factor 1 gene (43). (B) The
enlarged map indicates the 2,460-bp fragment that encodes enhancin (67.6 to
70.1 kbp on the viral genome). Restriction sites used in subcloning and sequencing of the gene are shown. ORF analysis of this fragment is shown in all six
reading frames. The black boxes indicate ORFs encoding sequences that are at
least 25 aa in length and which begin with an ATG start codon as determined by
the MacVector program from International Biotechnologies, Inc. The shaded
box indicates the ORF corresponding to the LdMNPV enhancin gene.

ping studies revealed that these mutations were within the 25K
FP gene between 65.3 and 66.0 kbp (6, 7). During the sequencing of the 4.3-kbp fragment, an open reading frame (ORF)
which initiated within this fragment and proceeded through
the EcoRI site located at 68.9 kbp was discovered. The predicted amino acid sequence of this partial ORF was compared
with those of other proteins in GenBank at the National Center for Biotechnology Information by using the BLAST network server (1). This ORF exhibited homology to the enhancin
genes of the TnGV, PuGV, and HaGV. The entire ORF was
subcloned on a 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the
viral genome) into pBluescript SK1 to generate pDB126, and
the DNA sequence of the ORF was determined. The LdMNPV enhancin gene is located between 67.6 and 70.1 kbp on
the viral genome and is transcribed clockwise with respect to
the circular viral genome (Fig. 1A). A partial restriction map
and the ORF map of a 2.46-kbp fragment in this region are
presented in Fig. 1B, with the largest ORF (2,346 bp in frame
1) corresponding to the enhancin gene.
Characteristics of the nucleotide sequence. The nucleotide
sequence of the 2,460-bp fragment containing the LdMNPV
enhancin gene is presented in Fig. 2 along with the predicted
amino acid sequence of the protein. The enhancin ORF begins
at nucleotide position 49 and ends at position 2395. The gene
could encode a 782-amino acid (aa) protein with a predicted
molecular mass of 89,200 Da. Analysis of the sequence upstream of the enhancin ORF reveals a potential baculovirus
late promoter sequence, TTAAG, beginning 13 bp upstream of
the enhancin start codon (nucleotides 36 to 40 [Fig. 2]). Potential late baculovirus promoter motifs have also been identified upstream of the enhancin genes in the TnGV (ATAAG
[18]) and the PuGV (ATAAG [32]). In addition, enhancin
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FIG. 2. Nucleotide sequence of the 2,460-bp fragment containing the
LdMNPV enhancin gene and the predicted amino acid sequence. The consensus
late promoter sequence is shaded, with the late transcriptional start site underlined. The SstI restriction endonuclease site used in construction of the enhancin::cat virus is boxed. Oligonucleotides used in transcriptional mapping and primer
extension are underlined (see text).

transcripts have been shown to initiate within the HaGV late
promoter motif TTAAG (at the nucleotides underlined within
this sequence [32]).
Immediately downstream of the LdMNPV enhancin gene is
the hrf-1 gene (43), which is also transcribed in a clockwise
direction (Fig. 1A). There is no potential polyadenylation signal sequence that can be identified in the 119 bp between the
enhancin stop codon and the hrf-1 start codon. This is similar
to the TnGV, PuGV, and HaGV, which also lack canonical
polyadenylation signal sequences between the enhancin gene
and the downstream gene (ORF1) (18, 32). Despite the similarity between the LdMNPV and the GVs with respect to the
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organization of the enhancin gene and its downstream gene
(hrf-1 or ORF1), the LdMNPV hrf-1 gene shows no homology
to the GV ORF1 genes.
Characteristics of the protein sequence. The LdMNPV enhancin gene encodes a shorter protein than the GV enhancin
genes, with 782 aa for the LdMNPV enhancin compared to 901
or 902 aa for the GV enhancins. All four proteins show moderate homology at the N terminus and are less homologous at
the C-terminal end (Fig. 3A). The TnGV and PuGV enhancin
proteins are virtually identical, with only 15 residue changes
between the proteins for an overall 98% amino acid identity
(18, 32). The HaGV enhancin protein is less homologous to
the other two GV proteins (TnGV and PuGV), with 81%
amino acid identity (89% over the first 550 aa and 69% over
the last 350 aa) and 90% similarity when conservative residue changes are taken into consideration (Fig. 3B) (32). The
LdMNPV enhancin protein shows approximately 31% amino
acid identity (Fig. 3A) to each of the three GV enhancin
proteins (32.1% to the TnGV protein, 32.2% to the PuGV
protein, and 31.4% to the HaGV protein), with approximately
55% similarity (54.7% to the TnGV protein, 55.2% to the
PuGV protein, and 55.6% to the HaGV protein). Overall the
four proteins exhibit 29% amino acid identity, with four areas
exhibiting greater than 50% amino acid identity (residues 59 to
67 at 78%, 196 to 290 at 51%, 451 to 468 at 58%, and 692 to
704 at 54% [Fig. 3B]).
Comparison of the LdMNPV enhancin amino acid sequence
with sequences in the BLOCKS database (version 9.0, December 1995 [19]) revealed the presence of a signature pattern
characteristic of a zinc-binding domain found within metalloproteases (25, 30). The signature pattern, HEXXH, is sufficient
to group a protein into the metalloprotease superfamily. All
four of the enhancin proteins have this conserved metalloprotease zinc-binding domain (residues 241 to 246 for the
LdMNPV) within a larger region of the protein, and all four
exhibit 51% amino acid identity in this region (residues 196 to
290 [Fig. 3]). For this type of enzyme, the zinc ion is chelated
by the two histidine residues in this sequence and by a third
residue, typically a histidine, cysteine, or aspartic or glutamic
acid residue, located anywhere from 20 to 120 aa downstream
of the HEXXH sequence (for reviews, see references 17 and
24). There are two aspartic acid and two glutamic acid residues
between 20 and 120 aa from the HEXXH sequence which are
conserved in all four enhancin proteins (LdMNPV residues
269, 289, 297, and 302), any of which could function as a
third zinc-binding ligand in the enhancin proteins (Fig. 3A). In
the metalloproteases, the glutamic acid residue within the
HEXXH sequence is the catalytic base which polarizes a water
molecule involved in the nucleophilic attack of the peptide
bond to be cleaved. Recently, it has been demonstrated that
the TnGV enhancin gene encodes a metalloprotease (27) that
is capable of degrading an insect intestinal mucin in the T. ni
larval midgut (46).
In vitro transcription and translation of the enhancin gene.
To demonstrate that the enhancin ORF encoded a protein, the
gene was expressed from pDB126 in a rabbit reticulocyte coupled transcription and translation system. Plasmid pDB126
contains the 4.2-kbp SstII fragment (67.0 to 71.2 kbp on the
viral genome) and has the enhancin gene under the control of
the T7 polymerase. Several radiolabeled bands, with apparent
molecular masses ranging from 25 to 88 kDa, were visualized
after analysis by SDS-PAGE and autoradiography (Fig. 4). The
size of the enhancin protein is predicted to be 89 kDa from the
nucleotide sequence. The smaller bands may correspond to
translation initiation at internal methionine-encoding bases
within the enhancin ORF or could be degradation products of
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FIG. 3. Alignment of the enhancin proteins with CLUSTAL W version 1.6 (44). (A) Amino acid alignment of the LdMNPV protein with the enhancins of TnGV
(18), PuGV (32), and HaGV (32). Shaded boxes indicate identical residues conserved in the four enhancin proteins. Identical residues within the conserved zinc-binding
domain of all metalloproteases are in black boxes. (B) Schematic showing the percent amino acid identity (boxed numbers) within regions of the different enhancin
proteins. Regions exhibiting the greatest amino acid identity are shaded. LdMNPV enhancin is compared to the three GV proteins, while TnGV and PuGV enhancins
are compared with the HaGV protein.
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FIG. 4. SDS-PAGE analysis after expression of enhancin under the control
of the T7 promoter. Shown is an autoradiograph of enhancin expressed in a
rabbit reticulocyte transcription and translation system and labeled with
[35S]Met. Lane 1, control plasmid, pBluescript SK1; lane 2, pDB126 expressing
enhancin. Molecular mass standards are indicated to the left, and the position of
the enhancin protein is indicated to the right.

the enhancin protein itself. No radiolabeled bands were detected for the parent plasmid pBluescript SK1 (Fig. 4).
Temporal analysis and primer extension mapping of the
enhancin transcripts. A 30-base oligonucleotide complementary to nucleotide positions 939 to 968 (Fig. 2) was used as a
strand-specific probe to characterize the temporal expression
of the LdMNPV enhancin gene. The enhancin gene is transcribed primarily as a 3.5-kb transcript at late times, 48 and
72 h p.i. (Fig. 5). Two smaller RNA species (1.2 and 1.5 kb)
also appear to be expressed at these times, although at lower
levels. The gene does not seem to be transcribed at a high level,
or else the transcripts are not very stable, since the blot shown
in Fig. 5 contained 150 mg of RNA per lane and required a
long exposure (3 weeks) for detection of the transcripts. The
3.5-kb transcript is quite large, as the LdMNPV enhancin ORF
is only 2.3 kbp in length. In comparison, the TnGV enhancin
gene is expressed as two late transcripts, 2.7 and 3.3 kb in

FIG. 5. Temporal analysis of the LdMNPV enhancin transcripts. L. dispar
652Y cells were infected with LdMNPV isolate A21-MPV, and cytoplasmic RNA
was isolated at the times indicated. RNA (150 mg) was separated by formaldehyde-agarose gel electrophoresis, blotted, and probed with a strand-specific
oligonucleotide complementary to positions 939 to 968 in the enhancin ORF
(Fig. 2). RNA from uninfected cells was used as a control (lane C). RNA size
standards are indicated on the left, and the sizes of the transcripts are indicated
on the right.

AN enhancin GENE IN THE L. DISPAR NPV

8137

FIG. 6. Determination of the 59 ends of the enhancin transcripts. Primer
extension analysis was performed for enhancin RNAs isolated at 48 and 72 h p.i.
RNA (40 mg) was incubated with an end-labeled 18-bp primer that is complementary to the enhancin nucleotide sequence at positions 132 to 149 (Fig. 2). The
primer was extended with Moloney murine leukemia virus reverse transcriptase.
Extension products were fractionated by PAGE and visualized by autoradiography. The sequencing ladder was generated with the same primer. The late
transcriptional start site is underlined. C, control.

length, in closer agreement with the size of the 2.7-kbp enhancin ORF in this virus (18).
To determine the transcriptional start site of the LdMNPV
enhancin transcripts, primer extension reactions were performed with an 18-base oligonucleotide that is complementary
to nucleotides 132 to 149 within the enhancin ORF (Fig. 2).
Transcription initiates at the first A residue (position 38 in Fig.
2) within the consensus baculovirus late promoter sequence
TTAAG (Fig. 6). Since only one start site was detected, it is
possible that the large enhancin transcript initiates at this late
promoter upstream of the enhancin ORF, proceeds through
the enhancin and hrf-1 genes, and terminates at a potential
polyadenylation signal sequence (AATAAA) that has been
identified downstream of the hrf-1 gene (43). This polyadenylation signal sequence is 3.2 kbp downstream of the enhancin
late promoter. Analysis of HaGV enhancin RNAs by RNase
protection assay also indicated that the HaGV enhancin gene
and the downstream ORF1 gene may be part of the same
bicistronic message (32) and therefore similar to enhancin gene
transcription in LdMNPV.
Construction of the enhancin::cat virus. Since purified enhancin can increase the potency of the AcMNPV (45), a virus
in which the LdMNPV enhancin gene was disrupted was constructed, in order to determine if the protein has an effect on
LdMNPV potency. Plasmid pDB108 has the 4.3-kbp BamHI/
EcoRI fragment (located at 64.5 to 68.8 kbp on the viral genome) containing approximately 1.1 kbp of the portion of
enhancin which encodes the N-terminal end (Fig. 7). It also
contains approximately 3.2 kbp of upstream sequence and has
an SstI site 223 bp downstream of the enhancin ATG start
codon (Fig. 2). The insert used to disrupt the gene was a
fragment containing the cat gene that was isolated on a 0.7-kbp
SstI cassette from pDB4 (8). The promoter- and terminatorless
cat gene was cloned into the SstI site within the enhancin gene
to generate pDB159. This construct has the cat gene inserted
at codon 76 in the noncoding orientation with respect to the
enhancin ORF (Fig. 7). Since the cat gene is not translationally
fused and in the opposite direction to the enhancin ORF, it can
be used only as a marker to identify the recombinant virus
(through hybridization) and not for studies of gene expression
from the enhancin promoter. Analysis of the DNA sequence of
the insert predicts that a small transcript (approximately 454
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FIG. 7. Construction of the enhancin::cat virus. The 4.3-kbp BamHI/EcoRI fragment (64.5 to 68.9 kbp on the viral genome) containing the N terminus-encoding
portion of the enhancin gene was cloned from LdMNPV isolate A21-MPV into pUC18 to generate pDB108. A 0.7-kbp SstI fragment containing the cat gene was cloned
into the SstI site within the enhancin gene to generate pDB159.

bp in length) could still be expressed that initiates at the enhancin late promoter and terminates at a consensus polyadenylation signal sequence present in the cat gene insert. A small
fusion protein containing the first 76 aa of enhancin and 9
additional aa (from the cat gene insert) could be expressed
from the enhancin promoter. This fusion protein does not
contain the zinc-binding domain and is most likely not active.
The mutant was constructed and verified by Southern blot
analysis with the 4.3-kbp BamHI/EcoRI fragment as a probe
(Fig. 8). Viral DNA from A21-MPV and the enhancin::cat virus
was isolated and restricted with both BamHI and EcoRI. In
Fig. 8, lane 1, (A21-MPV), only the 4.3-kbp BamHI/EcoRI fragment hybridized with the probe, as expected. The enhancin::cat
virus (lane 2) has an additional EcoRI site at the start of the cat
gene; therefore, two fragments hybridized in this isolate: (i) a
0.9-kbp EcoRI fragment and (ii) a 4.1-kbp fragment from the
BamHI to the EcoRI site at the beginning of the cat gene (Fig.
8). This result confirms that the mutation was transferred to

the viral genome and that the enhancin ORF was disrupted
with the cat gene in this isolate.
Bioassay analysis of the enhancin::cat virus. Bioassays (diet
incorporation and droplet feeding) were conducted with L. dispar larvae infected with either A21-MPV or the enhancin::cat
virus. Both the diet incorporation and droplet feeding methods
revealed that inactivation of the enhancin gene resulted in a
drop in viral potency ranging from 1.4- to 4.0-fold as determined by Probit analysis (Table 1). Although it is hard to determine the exact degree of the drop in potency due to the
close LC50s for both viruses, in all four bioassays the enhancin::
cat virus was less potent than A21-MPV. The fiducial limits of
the LC50s for A21-MPV and the enhancin::cat virus did not
overlap in the droplet feeding bioassay. The droplet feeding
bioassay was used to verify the results of the diet incorporation
bioassays since the former method is more accurate for close
LC50s and yields smaller standard deviations than the diet
incorporation method (22). The drop in potency in the four
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FIG. 8. Southern blot analysis of the enhancin::cat virus. Budded-virus DNA isolated from cells infected with either A21-MPV or the enhancin::cat virus was
restricted with BamHI and EcoRI. Digests were electrophoresed on a 1% agarose-Tris-borate-EDTA gel, blotted, and probed with the 4.3-kbp BamHI/EcoRI fragment
containing the N terminus-encoding portion of the enhancin gene. Lane 1, A21-MPV viral DNA; lane 2, enhancin::cat viral DNA. DNA size markers are indicated to
the left (in kilobase pairs), and the positions of the viral fragments are indicated to the right. Partial restriction maps of both A21-MPV and the enhancin::cat virus are
shown to the right, with the locations of the enhancin ORF and the inserted cat fragment indicated.

bioassays was analyzed by the unpaired t test (P 5 0.0125) and
by analysis of variance (P , 0.05) and was found to be significant. In the droplet feeding method, the volume ingested by
neonate L. dispar larvae was determined to be 176.5 6 37.1 nl
(data not shown). Based on this volume, the 50% lethal doses
were 17.9 6 2.4 polyhedra per larva for the enhancin::cat virus
and 8.7 6 1.0 polyhedra per larva for A21-MPV. Analysis of
the time-mortality response showed similar killing speeds for
the two viruses (data not shown). Therefore, the enhancin
protein has an effect on the potency of the virus but not on the
killing speed of the virus.
Previously it was reported that LdMNPV is evolutionarily
more distant from AcMNPV than are other NPVs, based on

TABLE 1. Effect of enhancin on the biological activity of LdMNPV
Assay no.a

1
2
3
4
a

Virus

A21-MPV
enhancin::cat
A21-MPV
enhancin::cat
A21-MPV
enhancin::cat
A21-MPV
enhancin::cat

virus
virus
virus
virus

LC50 (95% FL)b

Ratioc

13.5 (7.6–24.0)
19.0 (9.7–38.1)
24.6 (14.1–43.2)
76.1 (23.6–287.2)
6.7 (3.9–11.3)
21.2 (11.1–40.9)
45.4 (31.1–68.6)
181.6 (78.7–232.6)

1.4
3.1
3.2
4.0

Assays 1 to 3, diet incorporation; assay 4, droplet feeding.
Values are numbers of polyhedra per microliter of diet (assays 1 to 3) or
solution (assay 4). FL, fiducial limits.
c
enhancin::cat virus LC50/A21-MPV LC50.
b

phylogenetic analysis of the known polyhedrin gene sequences
from several baculoviruses (48). The finding of an enhancin
gene in the LdMNPV supports the polyhedrin gene phylogeny.
In addition, the presence of the LdMNPV enhancin gene may
suggest that the LdMNPV is more closely related to the GVs
than is the AcMNPV. Since the LdMNPV has an additional 29
kbp of DNA that is not present in the AcMNPV, it is possible
that other homologous genes possessed by both the GVs and
the LdMNPV will be identified as more sequence data become
available.
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